Paperpal Prime Logo

European Journal of Pharmaceutics and Biopharmaceutics : Impact Factor & More

eISSN: 1873-3441pISSN: 0939-6411

Aims and Scope of European Journal of Pharmaceutics and Biopharmaceutics

The European Journal of Pharmaceutics and Biopharmaceutics is a peer-reviewed medical journal and the official journal of the International Association for Pharmaceutical Technology. It publishes research on pharmaceutical technology, pharmaceutical biotechnology, and biopharmaceutics. Less

Key Metrics

CiteScore
9.7
Eigenfactor
0.01 - 0.05
Impact Factor
< 5
SJR
Q1Biotechnology
SNIP
1.21
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on European Journal of Pharmaceutics and Biopharmaceutics

European Journal of Pharmaceutics and Biopharmaceutics Journal Specifications

Overview
Publisher ELSEVIER
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1991
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in European Journal of Pharmaceutics and Biopharmaceutics ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in European Journal of Pharmaceutics and Biopharmaceutics

Buprenorphine long acting injectables: clinical needs, pharmacodynamic and pharmacokinetic basis, and design challenges for solid preformed implants
  • 1 Sep 2026
  • European Journal of Pharmaceutics and Biopharmaceutics
Mechanistic enhancement of oral bioavailability through a coamorphous apremilast-aceclofenac systems: integrated LC-MS/MS Bioanalysis, in vivo pharmacokinetics, and PBPK modeling.
  • 1 Aug 2026
  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Local drug delivery for oral squamous cell carcinoma under oral cavity.
  • 1 Aug 2026
  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
The VitraCell: A new in vitro test setup for intravitreal dosage forms.
  • 1 Aug 2026
  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Radical scavenging reactivity of β2-agonists: Mechanistic insights into the antioxidant behavior of salbutamol and tulobuterol.
  • 1 Aug 2026
  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Cholesterol-butyl-biguanide conjugate as a novel excipient enhances the efficacy of doxorubicin liposomes against triple-negative breast cancer by potentiating immunogenic cell death.
  • 1 Aug 2026
  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Buprenorphine long acting injectables: clinical needs, pharmacodynamic and pharmacokinetic basis, and design challenges for solid preformed implants
  • 1 Sep 2026
  • European Journal of Pharmaceutics and Biopharmaceutics
Mechanistic enhancement of oral bioavailability through a coamorphous apremilast-aceclofenac systems: integrated LC-MS/MS Bioanalysis, in vivo pharmacokinetics, and PBPK modeling.
  • 1 Aug 2026
  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Local drug delivery for oral squamous cell carcinoma under oral cavity.
  • 1 Aug 2026
  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
The VitraCell: A new in vitro test setup for intravitreal dosage forms.
  • 1 Aug 2026
  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Radical scavenging reactivity of β2-agonists: Mechanistic insights into the antioxidant behavior of salbutamol and tulobuterol.
  • 1 Aug 2026
  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Cholesterol-butyl-biguanide conjugate as a novel excipient enhances the efficacy of doxorubicin liposomes against triple-negative breast cancer by potentiating immunogenic cell death.
  • 1 Aug 2026
  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

FAQs on European Journal of Pharmaceutics and Biopharmaceutics